Walid Kamoun, Vice President, Global Head of R&D Oncology at Servier, shared a post on LinkedIn:
“It was a pleasure to join the Tech and Drugs podcast to discuss how AI is reshaping oncology R&D, and why the conversation needs to move beyond hype and generic ‘transformation’ language.
In R&D, AI’s value lies not in replacing expertise, but in augmenting it: helping teams move faster, challenge assumptions earlier, and make stronger decisions.
But beyond the capabilities of the tools themselves, the real challenge remains adoption, successful AI integration requires a leadership mindset open to change, and the ability to collaborate with the right partners, internally and externally.
At Servier, we have fully embraced this innovation and embarked into an amazing journey with a very ambitious roadmap with a lazer focus on delivering transformative therapies to patients.
Thanks Thibault GEOUI, PhD for the opportunity to contribute and for the great discussion.”
Other articles about Servier on OncoDaily.